The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2021
Filed:
Feb. 22, 2019
Medtronic Vascular, Inc., Santa Rosa, CA (US);
Marc A. Anderson, Galway, IE;
Grainne Teresa Carroll, Galway, IE;
Paul Devereux, Galway, IE;
Niall Duffy, Galway, IE;
Matthew Fleming, Roscommon, IE;
Alexander J. Hill, Blaine, MN (US);
Elliot J. Howard, Redwood City, CA (US);
James R. Keogh, Maplewood, MN (US);
Marian Patricia Lally, Galway, IE;
Luke Lehmann, Newport Beach, CA (US);
Jeffrey Madden, Galway, IE;
Kevin M. Mauch, Windsor, CA (US);
Ciaran McGuinness, Roscommon, IE;
Brian T. McHenry, Golden Valley, MN (US);
Karl L. Olney, Tustin, CA (US);
Geoffrey Orth, Sebastopol, CA (US);
Edward Sarnowski, Newport Coast, CA (US);
Elizabeth A. Schotzko, Blaine, MN (US);
Benjamin Wong, Irvine, CA (US);
Medtronic Vascular, Inc., Santa Rosa, CA (US);
Abstract
Methods of transcatheter delivery of a prosthetic heart valve. A distal region of a guide member assembly is advanced into a heart of a patient. The distal region is docked to native anatomy of the heart. A delivery device, including a collapsed prosthetic heart valve, is advanced over the docked guide member assembly. The collapsed prosthetic heart valve is located at an implantation site. The prosthetic heart valve is deployed from the delivery device, and then the delivery device is removed from the patient. At least a portion of the guide member assembly is removed from the patient. In some embodiments, the docking structure is docked to one or more of native mitral valve leaflets, chordae in the left ventricle, or walls of the left ventricle as part of a transseptal mitral valve delivery procedure.